Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05637242 · ClinicalTrials.gov registry record
Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study
A clinical trial, sponsored by Corewell Health West.
- Terminated
- Registry status
- 371
- Enrollment target
NCT05637242: Clinical Trial study, sponsored by Corewell Health West.
NCT05637242 is a clinical trial that was terminated before completion, run by Corewell Health West. The registered enrollment target is 371 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05637242 was terminated before completion, sponsored by Corewell Health West.
- TERMINATED
- Registry status
- 371 participants
- Enrollment target
Study Summary
This study is meant to predict the outcome of VAD therapy, by forming a VAD registry for quality assessment, research, and real-time monitoring of patients on VAD therapy. The goal is to optimize the use of VAD therapy for patients, to create an online quality measurement tool for VAD treatment, and to create algorithms to estimate the prognosis for patients getting a VAD.
Primary Outcome
Mortality will be assessed yearly.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 371 participants |
| Start Date | 2016-02 |
| Est. Completion | 2024-05-29 |
Why NCT05637242 stopped before completion
NCT05637242 is an observational study that tracks outcomes without assigning an intervention. The registered 371 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05637242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05637242 about?
NCT05637242 is a clinical study titled "Ventricular Assist Device (VAD) Research Registry and Blood Sub-Study". This study is meant to predict the outcome of VAD therapy, by forming a VAD registry for quality assessment, research, and real-time monitoring of patients on VAD therapy. The goal is to optimize the use of VAD therapy for patients, to create an online quality measurement tool for VAD treatment, and...
What is the current status of trial NCT05637242?
This trial is currently terminated. The enrollment target is 371 participants. The study started on 2016-02. Estimated completion is 2024-05-29.
Who is sponsoring clinical trial NCT05637242?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05743673 · 371 participants
SHAPE Test for Preoperative Risk Stratification
- NCT05761847 · 371 participants · NA
Pediatric Medication Therapy Management Trial
- NCT04801589 · 372 participants · Phase 3
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
- NCT04879329 · 372 participants · Phase 2
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia